Noticias de Eulerpool Arch Biopartners

Arch Biopartners Eulerpool-AFX

Arch Biopartners Noticias de Acciones

Arch Biopartners es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Arch Biopartners.

• 16 de octubre ·

  Yahoo
  Arch Biopartners Arranges Non-Brokered Private Placement
• 3 de octubre ·

  Yahoo
  Closes Units for Debt Settlement
• 3 de octubre ·

  Thefly.com
  Arch Biopartners closes units for debt settlement
• 26 de septiembre ·

  Yahoo
  Units for Debt Settlement
• 26 de septiembre ·

  Thefly.com
  Arch Biopartners announces units for debt settlement
• 11 de septiembre ·

  Yahoo
  Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
• 5 de agosto ·

  Yahoo
  Arch Biopartners’ cilastatin enters Phase II trial for AKI prevention
• 2 de agosto ·

  Yahoo
  Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 de agosto ·

  GlobeNewswire
  Arch Biopartners? Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 de agosto ·

  Thefly.com
  Arch Biopartners announces cilastatin to participate in PONTIAC Phase II trial